Status:
RECRUITING
Advanced Translational Research on Childhood Leukemia
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Childhood Leukemia
Eligibility:
All Genders
Up to 18 years
Brief Summary
Prognosis of children with leukemia, the most common pediatric cancer, has improved markedly. Yet, relapse still occurs in 15-40% of patients with a probability of survival of \<50%, which is unlikely...
Detailed Description
The first part of the study aimed to investigate genomics and drug sensitivity profiling of childhood leukemia and its potential application for precision medicine. The second part of the study aimed...
Eligibility Criteria
Inclusion
- List of inclusion criteria:
- acute lymphoblastic leukemia (ALL) or
- acute myeloid leukemia (AML) or
- 3 .mixed phenotype acute leukemia (MPAL) or
- 4\. juvenile myelomonocytic leukemia (JMML) or
- 5\. myelodysplastic syndromes (MDS) or
- 6\. normal bone marrow donor
- List of exclusion criteria:
- This study will not recruit subjects who are unable to understand English or Chinese.
- Patient or parent refusal
Exclusion
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04478006
Start Date
July 1 2020
End Date
June 1 2026
Last Update
June 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Kong Children Hospital
Hong Kong, Hksar, China